[{"Assets_0_FY_USD":8764286000.0,"EarningsPerShareBasic_1_FY_USD":1.62,"EarningsPerShareBasic_4_FY_USD":11.27,"EarningsPerShareDiluted_1_FY_USD":1.5,"EarningsPerShareDiluted_4_FY_USD":10.34,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":1307112000.0,"NetIncomeLoss_1_FY_USD":173519000.0,"NetIncomeLoss_4_FY_USD":1198511000.0,"StockholdersEquity_0_FY_USD":6144078000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":115954000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":106338000.0,"Ticker":"REGN","CIK":"872589","name":"REGENERON PHARMACEUTICALS INC","OfficialName":"Regeneron Pharmaceuticals Inc. Common Stock","form":"10-K","period":"20171231","fy":"2017.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"77738004554.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20180208"}]